Stay updated with breaking news from Project Integrum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 has announced the opening of a new office in San Francisco California USA. The new space will aim to accelerate the globalization of Biocytogens businesses.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announced the launch of the “Nano 100 Project”, which aims to develop fully human nanobody drugs for over 100 targets.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) will present at the upcoming BIO-EUROPE conference in Leipzig, Germany on October 24-26 and virtually on November 2-4, 2022. Using
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the
Press release content from Business Wire. The AP news staff was not involved in its creation.